Literature DB >> 2666563

Inhibition of human macrophage colony formation by interleukin 4.

J H Jansen1, G J Wientjens, W E Fibbe, R Willemze, H C Kluin-Nelemans.   

Abstract

We investigated the effects of human rIL-4 on in vitro hematopoiesis. A profound inhibition of macrophage colony formation by IL-4 was observed, whereas colony growth of other lineages was not affected. Inhibition of macrophage colony growth was not restricted to GM-CSF-induced colony growth but was also present in cultures stimulated with M-CSF. This inhibition was not only observed in cultures of light density bone marrow cells, but also in cultures of monocyte- and T lymphocyte-depleted bone marrow cells. Since a similar inhibition was observed in cultures of CD34+HLA-DR+-enriched bone marrow cells, a direct action of IL-4 on monocyte-committed progenitor cells is suggested.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2666563      PMCID: PMC2189394          DOI: 10.1084/jem.170.2.577

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  11 in total

1.  Colony growth of normal and neoplastic cells in various concentrations of methylcellulose.

Authors:  H C Kluin-Nelemans; H W Hakvoort; J H Jansen; N Duinkerken; J F van den Burgh; J H Falkenburg; R Willemze
Journal:  Exp Hematol       Date:  1988-12       Impact factor: 3.084

2.  Modulation of phenotypic and functional properties of human peripheral blood monocytes by IL-4.

Authors:  A A te Velde; J P Klomp; B A Yard; J E de Vries; C G Figdor
Journal:  J Immunol       Date:  1988-03-01       Impact factor: 5.422

3.  Identification of a T cell-derived b cell growth factor distinct from interleukin 2.

Authors:  M Howard; J Farrar; M Hilfiker; B Johnson; K Takatsu; T Hamaoka; W E Paul
Journal:  J Exp Med       Date:  1982-03-01       Impact factor: 14.307

4.  Synergistic effects of purified recombinant human and murine B cell growth factor-1/IL-4 on colony formation in vitro by hematopoietic progenitor cells. Multiple actions.

Authors:  H E Broxmeyer; L Lu; S Cooper; R Tushinski; D Mochizuki; B Y Rubin; S Gillis; D E Williams
Journal:  J Immunol       Date:  1988-12-01       Impact factor: 5.422

5.  Interleukin-1 (22-K factor) induces release of granulocyte-macrophage colony-stimulating activity from human mononuclear phagocytes.

Authors:  W E Fibbe; J van Damme; A Billiau; P J Voogt; N Duinkerken; P M Kluck; J H Falkenburg
Journal:  Blood       Date:  1986-12       Impact factor: 22.113

Review 6.  B-cell stimulatory factor-1/interleukin 4.

Authors:  W E Paul; J Ohara
Journal:  Annu Rev Immunol       Date:  1987       Impact factor: 28.527

7.  Interleukin 4 (B-cell stimulatory factor 1) can enhance or antagonize the factor-dependent growth of hemopoietic progenitor cells.

Authors:  D Rennick; G Yang; C Muller-Sieburg; C Smith; N Arai; Y Takabe; L Gemmell
Journal:  Proc Natl Acad Sci U S A       Date:  1987-10       Impact factor: 11.205

8.  Effects of B cell stimulatory factor-1/interleukin 4 on hematopoietic progenitor cells.

Authors:  C Peschel; W E Paul; J Ohara; I Green
Journal:  Blood       Date:  1987-07       Impact factor: 22.113

9.  Human recombinant interleukin 4 induces Fc epsilon R2/CD23 on normal human monocytes.

Authors:  D Vercelli; H H Jabara; B W Lee; N Woodland; R S Geha; D Y Leung
Journal:  J Exp Med       Date:  1988-04-01       Impact factor: 14.307

10.  Interleukin 4 induces cultured monocytes/macrophages to form giant multinucleated cells.

Authors:  A McInnes; D M Rennick
Journal:  J Exp Med       Date:  1988-02-01       Impact factor: 14.307

View more
  30 in total

Review 1.  Biological role of granulocyte macrophage colony-stimulating factor (GM-CSF) and macrophage colony-stimulating factor (M-CSF) on cells of the myeloid lineage.

Authors:  Irina Ushach; Albert Zlotnik
Journal:  J Leukoc Biol       Date:  2016-06-28       Impact factor: 4.962

2.  Human dendritic cells handling of binding, uptake and degradation of free and IgG-immune complexed dinitrophenylated human serum albumin in vitro.

Authors:  M Larsson; J Berge; A G Johansson; U Forsum
Journal:  Immunology       Date:  1997-01       Impact factor: 7.397

Review 3.  Interleukin-4. A regulatory protein.

Authors:  J H Jansen; W E Fibbe; R Willemze; J C Kluin-Nelemans
Journal:  Blut       Date:  1990-05

4.  Interleukin 4 suppresses the spontaneous growth of chronic myelomonocytic leukemia cells.

Authors:  K Akashi; T Shibuya; M Harada; Y Takamatsu; N Uike; T Eto; Y Niho
Journal:  J Clin Invest       Date:  1991-07       Impact factor: 14.808

Review 5.  Targeting Granulocyte-Monocyte Colony-Stimulating Factor Signaling in Rheumatoid Arthritis: Future Prospects.

Authors:  Chiara Crotti; Elena Agape; Andrea Becciolini; Martina Biggioggero; Ennio Giulio Favalli
Journal:  Drugs       Date:  2019-11       Impact factor: 9.546

6.  Efficient ex vivo generation of human dendritic cells from mobilized CD34+ peripheral blood progenitors.

Authors:  K Ohishi; N Katayama; H Mitani; H Araki; M Masuya; H Suzuki; N Hoshino; H Miyashita; K Nishii; S Kageyama; N Minami; H Shiku
Journal:  Int J Hematol       Date:  2001-10       Impact factor: 2.490

7.  Role of macrophage colony-stimulating factor in the differentiation and expansion of monocytes and dendritic cells from CD34+ progenitor cells.

Authors:  A W Kamps; D Hendriks; J W Smit; E Vellenga
Journal:  Med Oncol       Date:  1999-04       Impact factor: 3.064

8.  Interleukin-4 suppresses granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor levels in stimulated human monocytes.

Authors:  J A Hamilton; G A Whitty; A K Royston; J Cebon; J E Layton
Journal:  Immunology       Date:  1992-08       Impact factor: 7.397

9.  Validation of a high-throughput methodology to assess the effects of biomaterials on dendritic cell phenotype.

Authors:  Peng Meng Kou; Julia E Babensee
Journal:  Acta Biomater       Date:  2010-01-22       Impact factor: 8.947

10.  Growth factors controlling interleukin-4 action on hematopoietic progenitors.

Authors:  A Ferrajoli; T F Zipf; M Talpaz; E A Felix; Z Estrov
Journal:  Ann Hematol       Date:  1993-12       Impact factor: 3.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.